Repurposing resources to take on COVID-19

KAIMRC is working hard to contribute to the search for an effective treatment for COVID-19.

@Ashraf Habib

Editorial Corner

The feature articles in KAIMRC Innovations offer a closer look at issues of science not just related to researchers, but also to the wider community. They offer a window into all the interesting things happening at KAIMRC, and also informs policymakers and society of the importance of science in transforming communities all around the world. With regular updates, this is the place to learn all about KAIMRC, its facilities and the people behind its pioneering work.

Leaders chart the path for more clinical trials

April 14, 2020

Researchers, regulators, and experts from the medical industry gathered for the tenth year to share knowledge and exchange experiences on advancing the medical field through translational research

The importance of clinical trials for Saudi healthcare

April 12, 2020

Experts at the forum stressed the importance of clinical trials for better healthcare and for localizing the biopharmaceutical industries  KAIMRC 

Researchers aim to grow translational research

April 12, 2020

Forum participants made suggestions about how Saudi Arabia can reach its ambitious 2030 targets to increase clinical trials from six trials per 1,000 doctors to 100 trials, and capture 1% of the global $1.5 billion annual pharmaceutical investments in clinical trials 

KAIMRC leads the kingdom into the first phase I clinical trial 

April 12, 2020

The forum celebrated the success of a three-year push that led to KAIMRC kicking off the first phase I clinical trial to be held in Saudi Arabia, testing a potential vaccine against MERS-CoV 

Revolutionizing the clinical research landscape in Saudi Arabia

January 26, 2020

Ahmed Alaskar, executive director of KAIMRC, discusses how his institute is spearheading an initiative to develop clinical trials in the kingdom

Welcome from the Executive Director

July 1, 2016

KAIMRC sets its eyes on becoming a regional leader in biomedical research.

MORE